{
  "ticker": "AFP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962621",
  "id": "02962621",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250627",
  "time": "0731",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l51mt4ngvpc7.pdf",
  "summary": "**Director Shareholding Disclosure (AFT Pharmaceuticals Limited)**  \n- **Director**: Hartley Campbell Atkinson (trustee of Atkinson Family Trust)  \n- **Transaction**: Acquired **17,755** ordinary shares via inheritance at **zero consideration** (25-Jun-25).  \n- **Total holdings post-transaction**:  \n  - **Atkinson Family Trust**: **72,059,496** shares (from 72,041,741).  \n  - **Personal holdings**: **867,826** shares (unchanged).  \n- **Closed period trading**: No breach.  \n\n**No material trading or capital markets impact identified** (routine disclosure of director interest change).",
  "usage": {
    "prompt_tokens": 1380,
    "completion_tokens": 137,
    "total_tokens": 1517,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-26T21:53:02.991777"
}